MRI probes for sensing biologically relevant metal ions

Future Medicinal Chemistry

Volumn 2, Issue 3, 2010, Pages 367-384

  Bonnet, Célia S ^a   Tth, Éva ^a  

^a CENTRE DE BIOPHYSIQUE MOLÉCULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CALCIUM SENSING RECEPTOR; COPPER ION; GADOLINIUM; IRON; METAL COMPLEX; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; ZINC ION;

CALCIUM BINDING; CALCIUM SIGNALING; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; ELECTRON SPIN RESONANCE; MOLECULAR IMAGING; MOLECULAR PROBE; MOLECULAR RECOGNITION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SIGNAL DETECTION;

ANIMALS; CONTRAST MEDIA; GADOLINIUM; HUMANS; IONS; LANTHANOID SERIES ELEMENTS; MAGNETIC RESONANCE IMAGING; METAL NANOPARTICLES; METALS; MOLECULAR PROBES; MOLECULAR STRUCTURE; WATER;

EID: 77953416831     PISSN: 17568919     EISSN: None     Source Type: Journal    
DOI: 10.4155/fmc.09.161     Document Type: Review

References (81)

1. Faller P, Hureau C. Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-β peptide. Dalton Trans. 1080-1094 (2009).
2. Zecca L, Youdim MBH, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5, 863-873 (2004).
3. Sensi SL, Paoletti P, Bush AI, Sekler I. Zinc in the physiology and pathology of the CNS. Nat. Rev. Neurosci. 10, 780-791 (2009).
4. Que LE, Domaille DW, Chang CJ. Metals in neurobiology: probing their chemistry and biology with molecular imaging. Chem. Rev. 108, 1517-1549 (2008).
5. Merbach AE, Toth E (Eds). The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging. John Wiley & Sons, Chichester, UK (2001).
6. Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem. Rev. 99, 2293-2352 (1999).
7. Allen MJ, Meade TJ. Magnetic resonance contrast agents for medical and molecular imaging. Metal Ions Biol. Syst. 42, 1-38 (2004).
8. Aime S, Botta M, Terreno E. Gd(III)-based contrast agent for MRI. Adv. Inorg. Chem. 57, 173-237 (2005)
9. Geraldes CFGC, Laurent S. Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Media Mol. Imaging 4, 1-23 (2009).
10. Laurent S, Forge D, Port M et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 108, 2064-2110 (2008).
11. Aime S, Delli Castelli D, Terreno E. Novel pH-reporter MRI contrast: agents. Angew. Chem. Int. Ed. 41, 4334-4336 (2002).
12. Zhang S, Winter P, Wu K, Sherry AD. A novel europium(III)-based MRI contrast: agent. J. Am. Chem. Soc.123, 1517-1518 (2001).
13. Woods M, Woessner DE, Sherry AD. Paramagnetic lanthanide complexes as PARACEST agents for medical imaging. Chem. Soc. Rev. 35, 500-511 (2006).
14. Woessner DE, Zhang S, Mierritt ME, Sherry AD. Numerical solution of the Bloch equations provides insights into the optimum design of PARACEST agents for MRI. Magn. Reson. Med. 53, 790-799 (2005).
15. Sherry AD, Woods M. Chemical exchange saturation transfer contrast agents for magnetic resonance imaging. Annu. Rev. Biomed. Eng. 10, 391-411 (2008).
16. Chauvin T, Durand P, Bernier M et al. Detection of enzymatic activity by PARACEST MRI: a general approach to target a large variety of enzymes. Angew. Chem. Int. Ed. 47, 4370-4372 (2008).
17. Kubicek V, Toth E. Design and function of metal complexes as contrast agents in MRI. Adv. Inorg. Chem. 61, 63-129 (2009).
18. Yoo B, Pagel MD. An overview of responsive MRI contrast agents for molecular imaging. Front. Biosci. 13, 1733-1752 (2008).
19. De Leon-Rodriguez LM, Lubag AJM, Malloy CR, Martinez GV, Gillies RJ, Sherry AD. Responsive MRI agents for sensing metabolism in vivo. Acc. Chem. Res. 42, 948-957 (2009).
20. Major JL, Meade TJ . Bioresponsive, cell-penetrating and multimeric MR contrast agents. Acc. Chem. Res. 42, 893-903 (2009).
21. Que EL, Chang CJ. Responsive magnetic resonance imaging contrast agents as chemical sensors for metals in biology and medicine. Chem. Soc. Rev. 39, 51-60 (2010).
22. Forsen S, Kordel J. Calcium in biological systems. In: Bioinorganic Chemistry. Bertini I, Gray HB, Lippard SJ, Valentine JS (Eds). University Science Books, Mill Valley, California, USA, 107 (1994).
23. Somjen GG. Ions in the Brain: Normal function, Seizures, and Stroke. Oxford University Press, Oxford, UK (2004).
24. Koller CW Neuroprotective therapy for Parkinson's disease. Exp. Neurol. 144, 24-28 (1997).
25. 2+-dependent depolarization of rat and human mitochondria: relevance to Huntington's disease. Arch. Biochem. Biophys. 410, 1-6 (2003).
26. 2+ currents in mice dorsal root ganglion neurons. Neurosci. Lett. 235, 69-72 (1997).
27. Yarlagadda A. Role of calcium regulation in pathophysiology model of schizophrenia and possible interventions. Med. Hypotheses 58, 182-186 (2002).
28. Gailly P. New aspects of calcium signaling in skeletal muscle cells: implications in Duchenne muscular dystrophy. Biochim. Biophys. Acta 1600, 38-44 (2002).
29. Tsien RY, Waggoner A. In : Handbook of Biological Confical Microscopy (2nd Edition). Pawley JB (Ed.). Plenum Press, NY, USA, 267-280 (1995).
30. Tsien RY. A calcium-sensitive magnetic resonance imaging contrast agent. Chem. Eng. News 72, 34-44 (1994).
31. Czarnik AW (Ed.). ACS Symposium Series 538. American Chemical Society, Washington, DC, USA (1993).
32. Waters J, Larkum M, Sakmann B, Heimchen F. Supralinear Ca2+ influx into dendritic tufts of layer 2/3 neocortical pyramidal neurons in vitro and in vivo. J. Neurosci. 23, 8558-8567 (2003).
33. Kerr JND, Greenberg D, Heimchen F. From the cover: imaging input and output of neocortical networks in vivo. Proc. Natl. Acad. Sci. USA 102, 14063-14068 (2005).
34. Ohki K, Chung S, Ch'ng YH, Kara P, Reid RC. Functional imaging with cellular resolution reveals precise micro-architecture in visual cortex. Nature 433, 597-603 (2005).
35. Song SK, Hotchkiss RS, Neil J, Morris PE Jr, Hsu CY, Ackerman JJ. Determination of intracellular calcium in vivo via fluorine-19 nuclear magnetic resonance spectroscopy. Am. J. Physiol. 269, C318-C322 (1995).
36. Tsien RW, Tsien RY. Calcium channels, stores and oscillations. Annu. Rev. Cell Biol. 6, 715-760 (1990).
37. Meldolesi J. Calcium signaling: oscillations, activation and expression. Nature 392, 863-866 (1998).
38. 2+ signaling. Nat. Rev. Neurosci. 8, 182-193 (2007).
39. Logothetis NK. What we can do and what we cannot do with fMRI. Nature 453, 869-878 (2008).
40. Li W, Fraser SE, Meade TJ. A calciumsensitive magnetic resonance imaging contrast agent. J. Am. Chem. Soc. 12, 1413-1414 (1999).
41. 2+-dependent relaxivity, adapted to intracellular concentrations
42. Tsien RY. New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structures. Biochemistry 19, 2396-2404 (1980).
43. Li W, Parigi G, Fragai M, Luchinat C, Meade TJ. Mechanistic studies of a calcium-dependent MRI contrast agent. Inorg. Chem. 41, 4018-4024 (2002).
44. Hammoud DA, Hoffman JM, Porner MG. Molecular neuroimaging: from conventional to emerging techniques. Radiology 245, 21-42 (2007).
45. 3+ complexes. J. Biol. Inorg. Chem. 13, 35-46 (2008).
46. 3+ complexes: an attempt towards calcium sensitive MRI contrast agents. Inorg. Chem. 47, 1370-1381 (2008).
47. Angelovski G, Fousková P, Mamedov I, Canals, S, Toth E, Logothetis NK. Smart MRI agents sensing extracellular calcium fluctuations. ChemBioChem. 9, 1729-1734 (2008).
48. Dhingra K, Maier ME, Beyerlein M, Angelovski G, Logothetis NK. Synthesis and characterization of a smart contrast agent sensitive to calcium. Chem. Commun. 29, 3444-3446 (2008).
49. Atanasijevic T, Shusteff M, Fam P, Jasanoff A . Calcium-sensitive MRI contrast agents based on superparamagnetic iron oxide nanoparticles and calmodulin. Proc. Natl Acad. Sci. USA 103, 14707-14712 (2006).
50. Lin YJ, Koretsky AP. Manganese ion enhances T1-weighted MRI during brain activation: an approach to direct imaging of brain function. Magn Reson Med. 38, 378-388 (1997).
51. Koretsky AP, Silva AC. Manganese-enhanced magnetic resonance imaging (MEMRI). NMR Biomed. 17, 527-531 (2004).
52. This entire issue is dedicated to manganese-enhanced MRI.
53. Stipanuk MH. Biochemical, Physiological and Molecular Aspects of Human Nutrition. WB Saunders Company, PA, USA, 1043-1067 (2006).
54. Lipscomb WN, Sträter N. Recent advances in zinc enzymology Chem. Rev. 96, 2375-2433 (1996). (Pubitemid 126641107)
55. Maret W, Li. Y. Coordination dynamics of zinc in proteins Chem. Rev. 109, 4682-4707 (2009).
56. Zalewski P, Truong-An A, Lincoln S et al. Use of a zinc fluorophore to measure labile pools of zinc in body fluids and cellconditioned media. BioTechnique 40, 509-519 (2006).
57. Frederickon CJ, Koh JY, Bush AI. The neurobiology of zinc in health and disease. Nat. Rev. Neurosci. 6, 449-462 (2005).
58. Kikuchi K, Komatsu K, Nagano T. Zinc sensing for cellular applications. Curr. Opin. Chem. Biol. 8, 182-191 (2004).
59. Hanaoka K, Kikuchi K, Urano Y, Nagano T. Selective sensing of zinc ions with a novel magnetic resonance imaging contrast agent. J. Chem. Soc. Perkin Trans. 2, 1040-1043 (2001).
60. Hanaoka K, Kikuchi K, Urano Y et al. Design and synthesis of a novel magnetic resonance imaging contrast agent for selective sensing of zinc ion. Chem. Biol. 9, 1027-1032 (2002).
61. II::-activated resonance imaging agents. Inorg. Chem. 47, 10788-10795 (2008).
62. Major JL, Parigi G, Luchinat C, Meade TJ. The synthesis and in vitro testing of a zinc-activated MRI contrast agent. Proc. Natl Acad. Sci. USA 104, 13881-13886 (2007).
63. Zhang X, Lovejoy KS, Jasanoff A, Lippard SJ. Water-soluble porphyrins as a dual-function molecular imaging platform for MRI and fluorescence zinc sensing. Proc. Natl Acad. Sci. USA 104, 10780-10785 (2007).
64. Esqueda AC, López JA, Andreu-de-Riquer G et al. A. new gadolinium-based MRI zinc sensor J. Am. Chem. Soc. 131, 11387-11391 (2009).
65. Trokowski R, Ren J, Kaiman FK, Sherry AD. Selective sensing of zinc ions with a PARACEST contrast agent. Angew. Chem. Int. Ed. Engl. 44, 6920-6923 (2005).
66. Drayer B, Burger P, Darwin R, Riederer S, Herfkens R, Johnson GA. MRI of brain iron. AJR. 147, 103-110 (1986).
67. Ruloff R, van Koten G, Merbach AE. Novel, heteroditopic chelate for self-assembled gadolinium(III) complex with high relaxivity. Chem. Commun. 842-843 (2004).
68. 2 (M = Fe, Ru) complexes of a terpyridine-based heteroditopic chelate: a class of candidate for MRI contrast agents. J. Am. Chem. Soc. 127, 5147-5157 (2005).
69. Livramento JB, Toth E, Sour A, Borel A, Merbach AE, Ruloff R. High relaxivity confined to a small molecular space: a metallostar-based, potential. MRI contrast agent. Angew. Chem. Int. Ed. Engl. 44, 1480-1484 (2005).
70. Livramento JB, Weidensteiner C, Prata MIM et al. First in vivo MRI assessment of a self-assembled metallostar compound endowed with a remarkable high field relaxivity. Contrast Med. Mol. Imaging 1, 30-39 (2006).
71. 3+ ions. Chem. Eur. J. 12, 989-1003 (2006).
72. Parac-Vogt TN, Vander Eist L, Kimpe K, et al. Pharmocokinetic and in vivo evaluation of a self assembled gadolinium (III) iron (II) contrast agent with high relaxivity. Contrast Med. Mol. Imaging 1, 267-278 (2006).
73. Paris J, Gameiro C, Humblet V, Mohapatra PK, Jacques V, Desreux JF. Auto-assembling of ditopic macrocyclic lanthanide chelates with transition metal ions. Rigid multimetallic high relaxivity contrast agents for magnetic resonance imaging. Inorg. Chem. 45, 5092-5102 (2006).
74. III heterobimetallic complexes of DTPA-bis-salicylamide. Spectrochimica Acta 9, 1315-1322 (1993).
75. Jacques V, Desreux JF. New classes of MRI contrast agents. Top. Curr. Chem. 221, 125-164 (2002).
76. Halliwell B, Gutteridge JM. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 219, 1-14 (1984).
77. Gaggelli E, Kozlowsky H, Valensin D et al. Copper homeostasis and neurodegenerative disorders (Alzheimer's prion, and Parkinson's diseases and amyotrophic lateral sclerosis). Chem. Rev. 106, 1995-2044 (2006).
78. Waggoner DJ, Bartnikas TB, Gitlin JD. The role of copper in neurodegenerative disease. Neurohiol. Dis. 6, 221-230 (1999).
79. Que EL, Chang CJ. A smart magnetic resonance contrast agent for selective copper sensing. J. Am. Chem. Soc. 128, 15942-15943 (2006).
80. Que EL, Gianolio E, Baker SL, Wong AP, Aime S, Chang CJ. Copper-responsive magnetic resonance imaging contrast agents. J. Am. Chem. Soc. 131, 8527-8536 (2009).
81. Que EL, Gianolio E, Baker SL, Aime S, Chang CJ. A copper-activated magnetic resonance imaging contrast agent with improved turn-on relaxivity response and anion compatibility. Dalton Trans. 39, 469-476 (2010).